<DOC>
	<DOC>NCT02323308</DOC>
	<brief_summary>The aim of study is to describe the clinical, immunological, serological, virological and therapeutic characteristics of HIV+ patients harboring isolated anti-HBc profile and to assess the response to vaccination in these patients.</brief_summary>
	<brief_title>Isolated Anti-HBc Serological Profile in HIV Infected Patients: Immunological, Virological Characteristics and Response to Hepatitis B Vaccination</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>HIV+ adults patients negative HBsAg negative aHBs Ab positive HBc Ab without HBV vaccination CD4 cell above 200 /mm3 HIV viral load below 50 copies/mL positive HBs antigenemia in the past transaminitis above fivefold upper normal limit PT&lt;50% or Platelet &lt;50 000/mm3 ongoing opportunistic infection ongoing or recent systemic corticoid or immunomodulatory therapy, splenectomy, pregnancy, contraindication to intramuscular injection, familial history of neurological disease.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>